What is the recommended dose of Prospan (Ivy leaf extract) for pediatric and geriatric patients with cough, Chronic Obstructive Pulmonary Disease (COPD), or asthma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Prospan Dosing for Pediatric and Geriatric Patients

Prospan (ivy leaf extract EA 575) should be dosed at 2.5-5 mL twice daily for children under 6 years, 5 mL twice daily for children 6-12 years, and 5-7.5 mL twice daily for adolescents and adults, though it is important to note that major pediatric respiratory guidelines do not recommend herbal cough preparations as first-line therapy for chronic cough. 1, 2

Critical Context: Guideline-Based Approach First

Before considering Prospan, pediatric chronic cough (>4 weeks duration) requires systematic evaluation using pediatric-specific protocols to identify the underlying etiology. 3, 4

Management should be based on the etiology of cough, not empirical treatment. An empirical approach aimed at treating upper airway cough syndrome, GERD, or asthma should not be used unless other features consistent with these conditions are present. 4

Essential Initial Workup

  • Chest radiograph and age-appropriate spirometry (pre- and post-β2 agonist) are recommended for all children with chronic cough 3, 4
  • Additional tests should be individualized based on clinical symptoms and signs, not routinely performed 4

Prospan Dosing Recommendations

Pediatric Dosing (Based on Clinical Studies)

Children 0-6 years:

  • 2.5 mL (½ measuring cup) twice daily 2, 5
  • Can be used in infants under 1 year with similar safety profile 1

Children 6-12 years:

  • 5 mL (1 measuring cup) twice daily 2, 5

Adolescents >12 years:

  • 5-7.5 mL twice daily 2

Adult/Geriatric Dosing

Adults (including elderly):

  • 5-7.5 mL twice daily 6
  • Effervescent tablet formulation: 1½-2 tablets daily (97.5-130 mg dried ivy leaf extract) 7

Treatment Duration

  • Typical treatment course: 7-14 days 2, 6
  • Reassessment should occur after 7 days of treatment 6

Evidence Quality and Limitations

The evidence supporting Prospan consists primarily of observational studies and open-label trials, not high-quality randomized controlled trials. 1 A 2023 expert review concluded that while EA 575 has minimal side effects and may provide clinical benefits, more robust clinical trials are needed to confirm efficacy. 1

Reported Efficacy

  • Observational studies showed 92-97% improvement in cough symptoms in children and adults 2, 7
  • Comparative study found ivy leaf extract comparable to acetylcysteine for acute bronchitis 6
  • Adverse event rate: 0.2-1.9% (mild, non-serious events) 2, 7

Important Clinical Caveats

Prospan is not appropriate for:

  • Chronic wet/productive cough with specific cough pointers (digital clubbing, failure to thrive, abnormal chest radiograph) - these require investigation for underlying disease like protracted bacterial bronchitis or bronchiectasis 4
  • Cough associated with confirmed asthma - inhaled corticosteroids are first-line 8
  • Cough with features of GERD - treat according to GERD-specific guidelines, not with cough suppressants 4, 9

Never use over-the-counter cough suppressants (codeine, dextromethorphan, diphenhydramine) in children, as they are associated with significant morbidity and mortality without proven benefit. 8

When to Escalate Care

  • Chronic cough unresponsive to initial management requires specialist referral 4
  • Presence of specific cough pointers mandates further investigation (flexible bronchoscopy, chest CT, immunologic evaluation) 4
  • Post-tussive vomiting, paroxysmal cough, or inspiratory whoop suggests pertussis and requires specific testing 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.